Efficacy and safety of modified-release prednisone in patients with rheumatoid arthritis
Marco Krasselt, Christoph Baerwald Rheumatology Unit, Clinic for Gastroenterology and Rheumatology, Department of Internal Medicine, Neurology and Dermatology, University of Leipzig, Leipzig, Germany Abstract: The introduction of modified-release (MR) prednisone adds a drug with encouraging potent...
Main Authors: | Krasselt M, Baerwald C |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-03-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/efficacy-and-safety-of-modified-release-prednisone-in-patients-with-rh-peer-reviewed-article-DDDT |
Similar Items
-
Chronotherapy with low-dose modified-release prednisone for the management of rheumatoid arthritis: a review
by: Beltrametti SP, et al.
Published: (2016-11-01) -
The efficacy of low dose short-term prednisone therapy for remission induction in newly diagnosed rheumatoid arthritis patients
by: John M. Stacy, et al.
Published: (2021-08-01) -
Patterns of Prednisone Use in Patients with Rheumatoid Arthritis Initiating Treatment with Tocilizumab in Routine US Clinical Practice
by: Dimitrios A. Pappas, et al.
Published: (2019-06-01) -
Low-dose modified-release prednisone in axial spondyloarthritis: 3-month efficacy and tolerability
by: Bandinelli F, et al.
Published: (2016-11-01) -
Effectiveness of TOcilizumab in comparison to Prednisone In Rheumatoid Arthritis patients with insufficient response to disease-modifying antirheumatic drugs (TOPIRA): study protocol for a pragmatic trial
by: Matthijs S. van der Leeuw, et al.
Published: (2020-04-01)